SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-242617
Filing Date
2023-09-26
Accepted
2023-09-26 17:25:52
Documents
14
Period of Report
2023-09-26
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d487087d8k.htm   iXBRL 8-K 29433
2 EX-99.1 d487087dex991.htm EX-99.1 15103
6 GRAPHIC g487087g0926005430523.jpg GRAPHIC 2613
  Complete submission text file 0001193125-23-242617.txt   175222

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA biib-20230926.xsd EX-101.SCH 2859
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE biib-20230926_lab.xml EX-101.LAB 17235
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE biib-20230926_pre.xml EX-101.PRE 10818
8 EXTRACTED XBRL INSTANCE DOCUMENT d487087d8k_htm.xml XML 3204
Mailing Address 225 BINNEY STREET CAMBRIDGE MA 02142
Business Address 225 BINNEY STREET CAMBRIDGE MA 02142 7814642000
BIOGEN INC. (Filer) CIK: 0000875045 (see all company filings)

IRS No.: 330112644 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-19311 | Film No.: 231281349
SIC: 2836 Biological Products, (No Diagnostic Substances)